Milestone Pharmaceuticals... (MIST)
1.97
0.01 (0.51%)
At close: Jan 15, 2025, 3:59 PM
1.98
0.51%
After-hours Jan 15, 2025, 04:12 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 13.76M | 7.64M | 114.14M | 72.31M | 119.82M | 85.95M | 10.88M |
| Short-Term Investments | 52.24M | 56.95M | n/a | 70.00M | n/a | 29.00K | 16.03M |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | -2.68M | -926.00K | -1.29M | -929.00K | n/a | n/a |
| Receivables | 3.85M | 1.21M | 483.00K | 948.00K | 836.00K | 677.00K | 543.00K |
| Inventory | n/a | -331.00K | -356.00K | -725.00K | -578.00K | n/a | n/a |
| Other Current Assets | 3.18M | 6.00M | 4.30M | 5.43M | 1.84M | 1.40M | 100.00K |
| Total Current Assets | 73.03M | 71.80M | 118.92M | 148.69M | 122.50M | 88.05M | 27.55M |
| Property-Plant & Equipment | 2.19M | 2.68M | 926.00K | 1.29M | 929.00K | 30.00K | 35.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 2.19M | 2.68M | 926.00K | 1.29M | 929.00K | 30.00K | 35.00K |
| Total Assets | 75.23M | 74.48M | 119.85M | 149.97M | 123.43M | 88.08M | 27.59M |
| Account Payables | 3.98M | 2.26M | 4.38M | 4.64M | 4.38M | 2.60M | 4.00K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 546.00K | 990.00K | 448.00K | 490.00K | 660.00K | n/a | n/a |
| Other Current Liabilities | 2.70M | 2.89M | 1.94M | 1.03M | 3.29M | 1.87M | 1.60M |
| Total Current Liabilities | 7.23M | 6.14M | 6.78M | 6.16M | 8.33M | 4.53M | 1.60M |
| Long-Term Debt | 51.23M | 2.00M | 474.00K | 696.00K | 184.00K | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 138.76M | 59.10M |
| Total Long-Term Liabilities | 51.23M | 2.00M | 474.00K | 696.00K | 184.00K | 138.76M | 59.10M |
| Total Liabilities | 58.45M | 8.13M | 7.25M | 6.86M | 8.51M | 143.29M | 60.71M |
| Total Debt | 51.77M | 2.49M | 698.00K | 941.00K | 514.00K | n/a | n/a |
| Common Stock | 260.50M | 273.90M | 251.90M | 251.68M | 226.25M | 2.04M | 1.23M |
| Retained Earnings | -326.03M | -266.34M | -206.32M | -163.47M | -113.50M | -58.27M | -35.09M |
| Comprehensive Income | 48.46M | 34.35M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M |
| Shareholders Equity | 16.77M | 66.35M | 112.60M | 143.12M | 114.92M | -55.21M | -33.12M |
| Total Investments | 52.24M | 56.95M | n/a | 70.00M | n/a | 29.00K | 16.03M |